AR121268A1 - Tratamiento de la menorragia en pacientes con enfermedad de von willebrand grave mediante la administración de vwf recombinante - Google Patents
Tratamiento de la menorragia en pacientes con enfermedad de von willebrand grave mediante la administración de vwf recombinanteInfo
- Publication number
- AR121268A1 AR121268A1 ARP210100294A ARP210100294A AR121268A1 AR 121268 A1 AR121268 A1 AR 121268A1 AR P210100294 A ARP210100294 A AR P210100294A AR P210100294 A ARP210100294 A AR P210100294A AR 121268 A1 AR121268 A1 AR 121268A1
- Authority
- AR
- Argentina
- Prior art keywords
- von willebrand
- menorragia
- patients
- administration
- treatment
- Prior art date
Links
- 208000027276 Von Willebrand disease Diseases 0.000 title abstract 3
- 208000012137 von Willebrand disease (hereditary or acquired) Diseases 0.000 title abstract 3
- 208000007106 menorrhagia Diseases 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 108010047303 von Willebrand Factor Proteins 0.000 abstract 1
- 102100036537 von Willebrand factor Human genes 0.000 abstract 1
- 229960001134 von willebrand factor Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/37—Factors VIII
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Abstract
La presente se refiere a un método para tratar la menorragia en un sujeto con la enfermedad de von Willebrand (VWD) que comprende la administración al sujeto de una cantidad terapéutica de un factor de von Willebrand (rVWF).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202062969998P | 2020-02-04 | 2020-02-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR121268A1 true AR121268A1 (es) | 2022-05-04 |
Family
ID=74759563
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP210100294A AR121268A1 (es) | 2020-02-04 | 2021-02-04 | Tratamiento de la menorragia en pacientes con enfermedad de von willebrand grave mediante la administración de vwf recombinante |
Country Status (12)
Country | Link |
---|---|
US (1) | US20230398188A1 (es) |
EP (1) | EP4100048A1 (es) |
JP (1) | JP2023514541A (es) |
KR (1) | KR20220150303A (es) |
CN (1) | CN115335074A (es) |
AR (1) | AR121268A1 (es) |
AU (1) | AU2021216945A1 (es) |
BR (1) | BR112022015326A2 (es) |
CA (1) | CA3169996A1 (es) |
MX (1) | MX2022009492A (es) |
TW (1) | TW202134266A (es) |
WO (1) | WO2021158777A1 (es) |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
US3941763A (en) | 1975-03-28 | 1976-03-02 | American Home Products Corporation | PGlu-D-Met-Trp-Ser-Tyr-D-Ala-Leu-Arg-Pro-Gly-NH2 and intermediates |
JPS6023084B2 (ja) | 1979-07-11 | 1985-06-05 | 味の素株式会社 | 代用血液 |
US4640835A (en) | 1981-10-30 | 1987-02-03 | Nippon Chemiphar Company, Ltd. | Plasminogen activator derivatives |
US4496689A (en) | 1983-12-27 | 1985-01-29 | Miles Laboratories, Inc. | Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer |
US8597910B1 (en) | 1985-04-11 | 2013-12-03 | Children's Medical Center Corporation | DNA encoding Von Willebrand Factor (VWF) and methods and cells for producing VFW, and VFW produced by the DNA, methods and cells |
WO1986006096A1 (en) | 1985-04-11 | 1986-10-23 | The Children's Medical Center Corporation | Von willebrand factor |
EP0206448B1 (en) | 1985-06-19 | 1990-11-14 | Ajinomoto Co., Inc. | Hemoglobin combined with a poly(alkylene oxide) |
US4791192A (en) | 1986-06-26 | 1988-12-13 | Takeda Chemical Industries, Ltd. | Chemically modified protein with polyethyleneglycol |
AT405485B (de) | 1997-05-28 | 1999-08-25 | Immuno Ag | Eine das vwf-propeptid enthaltende pharmazeutische präparation |
WO2004039337A2 (en) | 2002-10-31 | 2004-05-13 | Protein Design Labs, Inc. | Stable liquid pharmaceutical formulation of antibodies that are prone to isomerization |
US20060094104A1 (en) | 2004-10-29 | 2006-05-04 | Leopold Grillberger | Animal protein-free media for cultivation of cells |
CN101163506B (zh) | 2004-12-27 | 2012-09-26 | 巴克斯特国际公司 | 聚合物-von Willebrand因子偶联物 |
LT1974014T (lt) | 2006-01-04 | 2017-11-27 | Baxalta Incorporated | Ląstelių kultūros terpė be oligopeptidų |
EP2601932A1 (en) | 2008-10-21 | 2013-06-12 | Baxter International Inc. | Lyophilized recombinant VWF formulations |
CN103097409A (zh) | 2010-07-08 | 2013-05-08 | 巴克斯特国际公司 | 在细胞培养物中生产重组高分子量vWF的方法 |
EP3858375B1 (en) | 2011-06-10 | 2024-03-20 | Takeda Pharmaceutical Company Limited | Treatment of coagulation disease by administration of recombinant vwf |
-
2021
- 2021-02-04 BR BR112022015326A patent/BR112022015326A2/pt unknown
- 2021-02-04 US US17/759,992 patent/US20230398188A1/en active Pending
- 2021-02-04 MX MX2022009492A patent/MX2022009492A/es unknown
- 2021-02-04 KR KR1020227030129A patent/KR20220150303A/ko unknown
- 2021-02-04 CA CA3169996A patent/CA3169996A1/en active Pending
- 2021-02-04 AR ARP210100294A patent/AR121268A1/es unknown
- 2021-02-04 EP EP21708526.5A patent/EP4100048A1/en active Pending
- 2021-02-04 TW TW110104257A patent/TW202134266A/zh unknown
- 2021-02-04 JP JP2022547192A patent/JP2023514541A/ja active Pending
- 2021-02-04 AU AU2021216945A patent/AU2021216945A1/en active Pending
- 2021-02-04 WO PCT/US2021/016592 patent/WO2021158777A1/en unknown
- 2021-02-04 CN CN202180023624.3A patent/CN115335074A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
MX2022009492A (es) | 2022-11-09 |
EP4100048A1 (en) | 2022-12-14 |
BR112022015326A2 (pt) | 2022-10-11 |
US20230398188A1 (en) | 2023-12-14 |
KR20220150303A (ko) | 2022-11-10 |
JP2023514541A (ja) | 2023-04-06 |
TW202134266A (zh) | 2021-09-16 |
WO2021158777A1 (en) | 2021-08-12 |
CN115335074A (zh) | 2022-11-11 |
CA3169996A1 (en) | 2021-08-12 |
AU2021216945A1 (en) | 2022-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Imbernón et al. | Chronic venous ulcer treatment with topical sevoflurane | |
ES2193159T3 (es) | Una formulacion de factor de coagulacion viii. | |
EA201400394A1 (ru) | Терапия глатирамером ацетатом с низкой кратностью | |
CO6220969A2 (es) | Adminsitracion semanal de inhibidores de peptidasa de dipeptidilo | |
RU2013123646A (ru) | Комбинированная композиция | |
RU2010151660A (ru) | Способы лечения множественной миеломы | |
Ozgul et al. | Effect of alkalinisation of lignocaine for propofol injection pain: a prospective, randomised, double-blind study | |
AR121268A1 (es) | Tratamiento de la menorragia en pacientes con enfermedad de von willebrand grave mediante la administración de vwf recombinante | |
PE20211199A1 (es) | Uso de reboxetina para el tratamiento de narcolepsia | |
CO2023014650A2 (es) | Dosificación y administración de l-asparaginasa recombinante | |
AR048806A1 (es) | Uso de cariofilenos en la elaboracion de medicamentos y tratamiento de afecciones corporales de inflamacion y dolor inflamatorio | |
CO2021006290A2 (es) | Dosificación subcutánea y administración de anticuerpos anti-c5 para el tratamiento de la hemoglobinuria paroxistica nocturna (pnh) | |
PE20221338A1 (es) | Metodos de tratamiento del cancer de pulmon de celulas pequenas con formulaciones de lurbinectedina | |
CO2020001314A2 (es) | Tratamiento de pacientes con enfermedad de von willebrand grave que se someten a cirugía electiva mediante administración de vwf recombinante | |
RU2016138790A (ru) | Композиции на основе сиалированных гликопротеинов и их применение | |
CO2020001322A2 (es) | Tratamiento de hemorragia gastrointestinal en pacientes con enfermedad de von willebrand grave mediante la administración de vwf recombinante | |
RU2710541C1 (ru) | Способ лечения ангулярного хейлита, возникшего вследствие дефицита рибофлавина | |
BR112017022478A2 (pt) | composição farmacêutica de liberação sustentada que contém rivastigmina | |
CO2021011340A2 (es) | Métodos de tratamiento profiláctico con vwf recombinante (rvwf) | |
RU2013148539A (ru) | Алиспоривир для лечения инфекции вируса гепатита с | |
Yutskovskaya et al. | Neck and chest: MesoCaHA for cheeks, neck, and décolletage | |
YUTSKOVSKAYA et al. | Neck and chest | |
US10835553B2 (en) | Application of hydroxypropyl methyl cellulose in preparation of medicine for treatment of esophageal mucosa | |
Yadav et al. | Comparison of dexmedetomidine and dexamethasone as an adjuvant to bupivacaine in supraclavicular block | |
RU2295349C2 (ru) | Способ лечения остеоартроза коленных суставов с использованием внутрисуставного введения препарата "хондролон" |